151 related articles for article (PubMed ID: 468310)
1. Inhibition of antibody-dependent cellular cytotoxicity by artificial immune complexes and pathological sera.
Howat JM; Moore M; Hilton AM; Kimber I
Immunology; 1979 Jun; 37(2):467-75. PubMed ID: 468310
[TBL] [Abstract][Full Text] [Related]
2. Serum factors influencing antibody-directed cell-mediated cytotoxicity (ADCC) and their effects on the detection of immune complexes by inhibition of ADCC.
Barkas T; Al-Khateeb SF
Immunology; 1979 Feb; 36(2):299-306. PubMed ID: 108202
[TBL] [Abstract][Full Text] [Related]
3. Antibody--antigen complex stimulated lysis of non-sensitized sheep red cells by human lymphocytes. I. Requirements for IgG complexes.
Fuson EW; Shaw MW; Hubbard RA; Lamon EW
Clin Exp Immunol; 1979 Oct; 38(1):158-65. PubMed ID: 316751
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulins (Ig) in circulating immune complexes (CIC) in cancer and inflammatory bowel disease (IBD).
Shafir M; Martinelli G; Bekesi JG; Jaramillo S; Heimann T; Aufses AH
Eur J Surg Oncol; 1986 Dec; 12(4):351-7. PubMed ID: 3780988
[TBL] [Abstract][Full Text] [Related]
5. Detection of rheumatoid factors of different isotypes and of circulating immune complexes in patients with inflammatory bowel disease.
Procaccia S; Bianchi Porro G; Colucci A; Villa P; Blasio R; Ardizzone S; Bonacina CA; Zanussi C
Boll Ist Sieroter Milan; 1990 Jun; 69(2):413-21. PubMed ID: 2152301
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
Neville ME; Hiserodt JC
J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
[TBL] [Abstract][Full Text] [Related]
7. Evidence against the presence of circulating immune complexes in chronic inflammatory bowel disease.
Soltis RD; Hasz D; Morris MJ; Wilson ID
Gastroenterology; 1979 Jun; 76(6):1380-5. PubMed ID: 155547
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of antibody-dependent cell-mediated cytotoxicity (ADCC) as a means of detection of immune complexes in the sera of patients with thyroid disorders and bronchogenic carcinoma.
Barkas T; AL-Khateeb SF; Irvine WJ; Davidson NM; Roscoe P
Clin Exp Immunol; 1976 Aug; 25(2):270-9. PubMed ID: 986262
[TBL] [Abstract][Full Text] [Related]
9. T-cell immunoregulation in patients with inflammatory bowel disease. II. Enhanced suppressor T-cell activity in ulcerative colitis.
Kramer JK; Depew WT; Szewczuk MR
J Clin Lab Immunol; 1988 Jan; 25(1):19-27. PubMed ID: 2968458
[TBL] [Abstract][Full Text] [Related]
10. Separation of cell-dependent antibody (CDA) and inhibitory antibody by protein-A affinity chromatography and the effect of fractions on antibody-dependent cellular cytotoxicity (ADCC).
Sato N; Yabuki Y; Toh K; Ishii Y; Kikuchi K
Immunology; 1979 Mar; 36(3):421-6. PubMed ID: 437836
[TBL] [Abstract][Full Text] [Related]
11. Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon.
Akiyama Y; Lubeck MD; Steplewski Z; Koprowski H
Cancer Res; 1984 Nov; 44(11):5127-31. PubMed ID: 6435864
[TBL] [Abstract][Full Text] [Related]
12. Unusually efficient tumor cell lysis by human effectors of antibody-dependent cellular cytotoxicity mediated by monoclonal antibodies.
Christiaansen JE; Sears DW
Cancer Res; 1984 Sep; 44(9):3712-8. PubMed ID: 6744288
[TBL] [Abstract][Full Text] [Related]
13. Circulating immune complexes in inflammatory bowel disease.
Jewell DP; MacLennan IC
Clin Exp Immunol; 1973 Jun; 14(2):219-26. PubMed ID: 4197968
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of expontaneous cytotoxicity and antibody dependency by rheumatoid synovial fluid].
Noguera Hernando E; Kreisler M; Durantez A; Larrea Gayarre A; de Landazuri MO; Cruz Martínez J
Allergol Immunopathol (Madr); 1978; 6(3):253-62. PubMed ID: 717203
[TBL] [Abstract][Full Text] [Related]
15. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
Alsheikhly AR; Wåhlin B; Andersson T; Perlmann P
J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of immune complex inhibition of antibody dependent cellular cytotoxicity in vitro by Staphylococcus-aureus protein A.
Cowan FM; Klein DL; Armstrong GR; Pearson JW
Biomedicine; 1979 Feb; 30(1):23-7. PubMed ID: 465637
[TBL] [Abstract][Full Text] [Related]
17. Antibody-mediated erythrolysis and erythrophagocytosis by human monocytes, macrophages and activated macrophages. Evidence for distinction between involvement of high-affinity and low-affinity receptors for IgG by using different erythroid target cells.
Rüegg SJ; Jungi TW
Immunology; 1988 Mar; 63(3):513-20. PubMed ID: 2965100
[TBL] [Abstract][Full Text] [Related]
18. Apparent sensitivity of human K lymphocytes to the spatial orientation and organization of target cell-bound antibodies as measured by the efficiency of antibody-dependent cellular cytotoxicity (ADCC).
Christiaansen JE; Burnside SS; Sears DW
J Immunol; 1987 Apr; 138(7):2236-43. PubMed ID: 3549899
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of antibody-dependent, cell-mediated cytotoxicity by serum from lepromatous leprosy patients.
de la Barrera SS; Sasiain MC; Geffner J; Isturiz MA; Segal-Eiras A; de Bracco MM
Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):218-24. PubMed ID: 4020209
[TBL] [Abstract][Full Text] [Related]
20. Two distinct mechanisms of cytotoxicity by porcine alveolar macrophages in antibody-dependent and immobilized immune complex-dependent cellular cytotoxicity.
Rothlein R; Kim YB
J Immunol; 1983 Sep; 131(3):1438-42. PubMed ID: 6687337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]